Human papillomavirus vaccinations at recommended ages: How a middle school-based educational and vaccination program increased uptake in the Rio Grande Valley

References

• Adjei Boakye E, Tobo BB, Rojek RP, Mohammed KA, Geneus CJ, Osazuwa-Peters N. Approaching a decade since HPV vaccine licensure: racial and gender disparities in knowledge and awareness of HPV and HPV vaccine. Hum Vaccin Immunother. 2017 11;13(11):1–7. doi:10.1080/21645515.2017.1363133.
   Web of Science ®Google Scholar
• Dochez C, Bogers JJ, Verhelst R, Rees H. HPV vaccines to prevent cervical cancer and genital warts: an update. Vaccine. 2014 Mar 20;32(14):1595–601. doi:10.1016/j.vaccine.2013.10.081.
   PubMed Web of Science ®Google Scholar
• Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst. 2011 Mar 2;103(5):368–83. doi:10.1093/jnci/djq562.
   PubMedGoogle Scholar
• Thomas TL, Strickland O, Diclemente R, Higgins M. An opportunity for cancer prevention during preadolescence and adolescence: stopping human papillomavirus (HPV)-related cancer through HPV vaccination. J Adolesc Health. 2013 May;52(5, Supplement):S60–68. doi:10.1016/j.jadohealth.2012.08.011.
   PubMed Web of Science ®Google Scholar
• Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999 Sep;189(1):12–19. doi:10.1002/(sici)1096-9896(199909)189:1<12:aid-path431>3.0.co;2-f.
   PubMed Web of Science ®Google Scholar
• Emiko Petrosky M, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M. Basic information about HPV-associated cancers. Centers for disease control and prevention. [accessed 2014 Aug 24]. https://www.cdc.gov/cancer/hpv/basic_info/
   Google Scholar
• Centers for Disease Control and Prevention. HPV-Associated cancers statistics; 2015. http://www.cdc.gov/cancer/hpv/statistics/index.htm
   Google Scholar
• Centers for Disease Control and Prevention Petrosky M, Bocchini JA Jr, MD, Hariri S PhD, Chesson H PhD, Curtis CR MD, Saraiya M MD, Unger ER MD, Markowitz LE MD. Use of 9-Valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64(11):300–04. 25811679.
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini Jr. JA, Unger ER. Centers for Disease Control and Prevention . Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations Rep. 2014 Aug 29;63(RR–05):1–30.
   PubMed Web of Science ®Google Scholar
• Shah PD, Gilkey MB, Pepper JK, Gottlieb SL, Brewer NT. Promising alternative settings for HPV vaccination of US adolescents. Expert Rev Vaccines. 2014 Feb;13(2):235–46. doi:10.1586/14760584.2013.871204.
   PubMed Web of Science ®Google Scholar
• Lee LY, Garland SM. Human papillomavirus vaccination: the population impact. F1000res. 2017;6:866. doi:10.12688/f1000research.10691.1.
   PubMedGoogle Scholar
• Bloem P, Ogbuanu I. Vaccination to prevent human papillomavirus infections: from promise to practice. PLoS Med. 2017 Jun;14(6):e1002325. doi:10.1371/journal.pmed.1002325.
   PubMed Web of Science ®Google Scholar
• Meites E , Kempe A , Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination - Updated recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2016;65(49):1405–08.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 - United States. MMWR Morb Mortal Wkly Rep. 2013 Jul 26;62(29):591–95.
   PubMed Web of Science ®Google Scholar
• President’s Cancer Panel Annual Report. 2012–2013. Accelerating HPV vaccine uptake: urgency for action to prevent cancer. [accessed 2018 Aug 29] http://deainfo.nci.nih.gov/advisory/pcp/annualReports/HPV/ExecutiveSummary.htm#sthash.PcA0EnNk.dpbs
   Google Scholar
• Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, Williams CL, Meyer SA, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States, 2016. MMWR Morb Mortal Wkly Rep. 2017 Aug 25;66(33):874–82. doi:10.15585/mmwr.mm6633a2.
   PubMed Web of Science ®Google Scholar
• Vanderpool RC, Stradtman LR, Brandt HM. Policy opportunities to increase HPV vaccination in rural communities. Hum Vaccines Immunotherapeutics. 2019;15(7–8):1527–32. doi:10.1080/21645515.2018.1553475.
   PubMed Web of Science ®Google Scholar
• Brandt HM, Vanderpool RC, Pilar M, Zubizarreta M, Stradtman LR. A narrative review of HPV vaccination interventions in rural U.S. communities. Prev Med. 2021 Apr;145:106407. doi:10.1016/j.ypmed.2020.106407.
   PubMed Web of Science ®Google Scholar
• Sanderson M, Coker AL, Eggleston KS, Fernandez ME, Arrastia CD, Fadden MK. HPV vaccine acceptance among Latina mothers by HPV status. J Women’s Health. 2009;18(11):1793–99. doi:10.1089/jwh.2008.1266.
   PubMed Web of Science ®Google Scholar
• Center for Reproductive Rights. Nuestro Voz, Nuestro Salud, Nuestro Texas: The Fight for Women’s Reproductive Health in the Rio Grande Valley; 2015. http://www.nuestrotexas.org/pdf/NT-spread.pdf
   Google Scholar
• AIDS Education and Training Centers National Coordinating Resource Center (AETC NCRC) Overview of HIV/AIDS in the Texas-Mexico Border Region. 2015. http://aidsetc.org/border/profile-texas
   Google Scholar
• Brown A. The unique challenges of surveying U.S. Latinos. 2015. http://assets.pewresearch.org/wp-content/uploads/sites/12/2015/11/2015-11-12_surveying-us-latinos.pdf
   Google Scholar
• Evans B, Quiroz RS, Athey L, McMichael J, Albright V, O‘Hegarty M, Caraballo RS . Customizing survey methods to the target population - Innovative approaches to improving; 2008. https://www.rti.org/sites/default/files/resources/evans_aapor08_paper.pdf
   Google Scholar
• O’Hegarty M, Pederson LL, Thorne SL, Caraballo RS, Evans B, Athey L, McMichael J. Customizing survey instruments and data collection to reach Hispanic/Latino adults in border communities in Texas. Am J Public Health. 2010 Aug 25;100(Suppl S1):S159–64. doi:10.2105/AJPH.2009.167338.
   PubMedGoogle Scholar
• CDC. HPV-associated cancers rates by race and ethnicity. Centers for disease control and prevention; 2018 [updated 2017 July 17]; [accessed 2018 June 12]. https://www.cdc.gov/cancer/hpv/statistics/race.htm
   Google Scholar
• Newman PA, Logie CH, Lacombe-Duncan A, Baiden P, Tepjan S, Rubincam C, Doukas N, Asey F. Parents’ uptake of human papillomavirus vaccines for their children: a systematic review and meta-analysis of observational studies. BMJ Open. 2018 Apr 20;8(4):e019206. doi:10.1136/bmjopen-2017-019206.
   PubMed Web of Science ®Google Scholar
• Anderson A, Taylor Z, Georges R, Carlson-Cosentino M, Nguyen L, Salas M, Vice A, Bernal N, Bhaloo T . Primary care physicians’ role in parental decision to vaccinate with HPV vaccine: learnings from a South Texas Hispanic patient population. J Immigr Minor Health. 2018 Oct;20(5):1236–42. doi:10.1007/s10903-017-0646-9.
   PubMed Web of Science ®Google Scholar
• Furgurson KF, Sandberg JC, Hsu FC, Mora DC, Quandt SA, Arcury TA. HPV knowledge and vaccine initiation among Mexican-Born farmworkers in North Carolina. Health Promot Pract. 2018 Mar 1;20(3):1524839918764671. doi:10.1177/1524839918764671.
   Web of Science ®Google Scholar
• Fleming WS, Sznajder KK, Nepps M, Boktor SW. Barriers and facilitators of HPV vaccination in the VFC program. J Community Health. 2018 Jun;43(3):448–54. doi:10.1007/s10900-017-0457-x.
   PubMed Web of Science ®Google Scholar
• Sherman SM, Nailer E. Attitudes towards and knowledge about Human Papillomavirus (HPV) and the HPV vaccination in parents of teenage boys in the UK. PLoS One. 2018;13(4):e0195801. doi:10.1371/journal.pone.0195801.
   PubMed Web of Science ®Google Scholar
• Donahue KL, Hendrix KS, Sturm LA, Zimet GD. Human papillomavirus vaccine initiation among 9-13-year-olds in the United States. Prev Med Rep. 2015 Jan 01;2:892–98. doi:10.1016/j.pmedr.2015.10.003.
   PubMedGoogle Scholar
• Brown B, Gabra MI, Pellman H. Reasons for acceptance or refusal of Human Papillomavirus Vaccine in a California pediatric practice. Papillomavirus Res. 2017 Jun;3:42–45. doi:10.1016/j.pvr.2017.01.002.
   PubMed Web of Science ®Google Scholar
• Clark SJ, Cowan AE, Filipp SL, Fisher AM, Stokley S. Understanding non-completion of the human papillomavirus vaccine series: parent-reported reasons for why adolescents might not receive additional doses, United States, 2012. Public Health Rep. 2016 May-Jun;131(3):390–95. doi:10.1177/003335491613100304.
   PubMed Web of Science ®Google Scholar
• Rutten LJ, St Sauver JL, Beebe TJ, Wilson PM, Jacobson DJ, Fan C, Breitkopf CR, Vadaparampil ST, Jacobson RM. Clinician knowledge, clinician barriers, and perceived parental barriers regarding human papillomavirus vaccination: association with initiation and completion rates. Vaccine. 2017 Jan 3;35(1):164–69. doi:10.1016/j.vaccine.2016.11.012.
   PubMed Web of Science ®Google Scholar
• Rodriguez AM, Do TQN, Jibaja-Weiss ML, Chen L, Schmeler KM, Montealnegre JR, KuoYK . Human papillomavirus vaccinations during the COVID-19 pandemic in middle schools in the Rio Grande Valley of Texas. Am J Public Health. 2022;112(9):1269–1272. doi:10.2105/ajph.2022.306970.
   PubMed Web of Science ®Google Scholar
• Kaul S, Do TQN, Hsu E, Schmeler KM, Montealegre JR, Rodriguez AM. School-based human papillomavirus vaccination program for increasing vaccine uptake in an underserved area in Texas. Papillomavirus Res. 2019;8(12):100189. doi:10.1016/j.pvr.2019.100189.
   PubMed Web of Science ®Google Scholar
• Victory M, Do TQN, Kuo Y-F, Rodriguez AM. Parental knowledge gaps and barriers for children receiving human papillomavirus vaccine in the Rio Grande Valley of Texas. Hum Vaccines Immunotherapeutics. 2019;15(7–8):1678–87. doi:10.1080/21645515.2019.1628551.
   PubMed Web of Science ®Google Scholar
• Meites ESP, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. Morbidity Mortality Weekly Rep. 2019;68(32):698–702. Centers for Disease Control and Prevention. external icon. http://dx.doi.org/10.15585/mmwr.mm6832a3
   PubMed Web of Science ®Google Scholar
• Henry KA, Swiecki-Sikora AL, Stroup AM, Warner EL, Kepka D. Area-based socioeconomic factors and human papillomavirus (HPV) vaccination among teen boys in the United States. BMC Public Health. 2017 07;18(1):19. doi:10.1186/s12889-017-4567-2.
   PubMed Web of Science ®Google Scholar
• Kornides ML, McRee AL, Gilkey MB. Parents who decline HPV vaccination: who later accepts and Why? Acad Pediatr. 2018 Mar;18(2S):S37–43. doi:10.1016/j.acap.2017.06.008.
   PubMed Web of Science ®Google Scholar
• Daley MF, Kempe A, Pyrzanowski J, Vogt TM, Dickinson LM, Kile D, Fang H, Rinehart DJ, Shlay JC. School-located vaccination of adolescents with insurance billing: cost, reimbursement, and vaccination outcomes. J Adolesc Health. 2014 Mar;54(3):282–88. doi:10.1016/j.jadohealth.2013.12.011.
   PubMed Web of Science ®Google Scholar
• Szilagyi PG, Humiston SG, Gallivan S, Albertin C, Sandler M, Blumkin A. Effectiveness of a citywide patient immunization navigator program on improving adolescent immunizations and preventive care visit rates. Arch Pediatr Adolesc Med. 2011 Jun;165(6):547–53. doi:10.1001/archpediatrics.2011.73.
   PubMed Web of Science ®Google Scholar
• Ejezie CL, Osaghae I, Ayieko S, Cuccaro P. Adherence to the recommended HPV vaccine dosing schedule among adolescents aged 13 to 17 years: findings from the national immunization survey-teen, 2019–2020. Vaccines (Basel). 2022 Apr 8;10(4):577. doi:10.3390/vaccines10040577.
   PubMed Web of Science ®Google Scholar
• Iversen OE, Miranda MJ, Ulied A, Sortel T, Lazarus E, Chokephaibulkit K, Block SL, Skrivanek A, Azurah AGN, Fong SM . Immunogenicity of the 9-Valent HPV vaccine using 2-dose regimens in girls and boys vs a 3-dose regimen in women. Comparative study multicenter study randomized controlled trial research support, Non-U.S. Gov’t. JAMA. 2016;316(22):2411–21. doi:10.1001/jama.2016.17615.
   PubMed Web of Science ®Google Scholar
• Margolis MA, Brewer NT, Shah PD, Calo WA, Alton Dailey S, Gilkey MB. Talking about recommended age or fewer doses: what motivates HPV vaccination timeliness? Hum Vaccin Immunother. 2021 Sep 2;17(9):3077–80. doi:10.1080/21645515.2021.1912550.
   PubMed Web of Science ®Google Scholar
• Rimer B, Harper H, Witte O. Accelerating HPV vaccine uptake: urgency for action to prevent cancer; a report to the president of the United States from the president’s cancer panel. Bethesda, MD: National Cancer Institute; 2014.
   Google Scholar
• Ashrawi D, Javaid M, Stevens L, Bello R, Ramondetta L. HPV vaccine uptake in Texas pediatric care settings: 2014-2015. 2015. (Houston, TX: MD Anderson Cancer Center). https://www.texascancer.info/pdfs/hpvenvironmentalscanreport.pdf
   Google Scholar
• Kempe A, Allison MA, Daley MF. Can school-located vaccination have a major impact on human papillomavirus vaccination rates in the United States? Acad Pediatr. 2018 Mar;18(2s):S101–s105. doi:10.1016/j.acap.2017.08.010.
   PubMedGoogle Scholar